MCID: ACT075
MIFTS: 56

Acute Myocardial Infarction

Categories: Blood diseases, Cardiovascular diseases, Genetic diseases, Oral diseases, Respiratory diseases

Aliases & Classifications for Acute Myocardial Infarction

MalaCards integrated aliases for Acute Myocardial Infarction:

Name: Acute Myocardial Infarction 38 12 55 15 73

Classifications:



External Ids:

Disease Ontology 12 DOID:9408
ICD10 33 I21 I21.9
ICD9CM 35 410 410.9 410.90
NCIt 50 C35204
SNOMED-CT 68 57054005
UMLS 73 C0155626

Summaries for Acute Myocardial Infarction

MalaCards based summary : Acute Myocardial Infarction is related to cardiac rupture and acute anterolateral myocardial infarction, and has symptoms including angina pectoris and chest pain. An important gene associated with Acute Myocardial Infarction is MIR208B (MicroRNA 208b), and among its related pathways/superpathways is A-beta Pathways: Plaque Formation and APP Metabolism. The drugs Dopamine and Metoclopramide have been mentioned in the context of this disorder. Affiliated tissues include heart, bone and endothelial, and related phenotype is cardiovascular system.

Related Diseases for Acute Myocardial Infarction

Diseases in the Myocardial Infarction family:

Myocardial Infarction 2 Acute Myocardial Infarction
Posterior Myocardial Infarction

Diseases related to Acute Myocardial Infarction via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 425)
# Related Disease Score Top Affiliating Genes
1 cardiac rupture 32.9 CRP PLAT
2 acute anterolateral myocardial infarction 32.5 ACE PIK3C2A
3 myocardial infarction 32.4 ACE ADRB1 CDKN2B-AS1 CRP F3 FABP3
4 cardiogenic shock 31.9 NPPB PIK3C2A PLAT
5 thrombosis 31.5 F3 PLAT SELP
6 left bundle branch hemiblock 31.5 ACE NPPB TNNI3
7 angina pectoris 31.4 ACE CRP NPPB PIK3C2A PLAT
8 myocarditis 31.2 MB NPPB TNNI3
9 ischemia 31.2 ACE MB PLAT SELP
10 coronary stenosis 31.1 ACE CRP NPPB PIK3C2A TNNI3
11 cardiac arrest 31.1 ACE NPPB PIK3C2A
12 arteries, anomalies of 31.1 ACE CRP F3 MB NPPB PLAT
13 atrial fibrillation 31.0 ACE ADRB1 CRP NPPB PLAT SELP
14 antiphospholipid syndrome 31.0 F3 PLAT SELP
15 coronary artery anomaly 30.8 ACE ADRB1 CRP FABP3 MB NPPB
16 thrombocytosis 30.7 CRP F3 SELP
17 endocarditis 30.7 CRP PIK3C2A PLAT TNNI3
18 ischemic heart disease 30.7 ACE CRP NPPB
19 atrial standstill 1 30.6 ACE ADRB1 NPPB TNNI3
20 pulmonary edema 30.6 ACE CRP NPPB PIK3C2A
21 aortic valve disease 1 30.5 ACE CRP NPPB TNNI3
22 systolic heart failure 30.5 ACE ADRB1 CRP NPPB
23 heart disease 30.5 ACE ADRB1 CRP F3 FABP3 NPPB
24 peripheral vascular disease 30.5 ACE CRP F3 PLAT SELP
25 pulmonary embolism 30.5 CRP F3 FABP3 NPPB PLAT TNNI3
26 sleep apnea 30.5 ACE CRP NPPB
27 disseminated intravascular coagulation 30.5 F3 MB PIK3C2A PLAT
28 cerebrovascular disease 30.5 ACE CRP PLAT SELP
29 vascular disease 30.4 ACE CRP F3 PLAT SELP
30 coronary heart disease 1 30.4 ACE ADRB1 CDKN2B-AS1 CRP NPPB PLAT
31 pericardial effusion 30.3 CRP NPPB PIK3C2A
32 diabetes mellitus, noninsulin-dependent 30.3 ACE CDKN2B-AS1 CRP MIR29A PLAT
33 platelet aggregation, spontaneous 30.3 PLAT SELP
34 arteriosclerosis 30.3 ACE CRP F3 SELP
35 congestive heart failure 30.3 ACE ADRB1 CDKN2B-AS1 MHRT NPPB
36 aortic valve disease 2 30.1 ACE CRP NPPB
37 toxic myocarditis 30.1 NPPB PIK3C2A TNNI3
38 respiratory failure 30.1 ACE CRP F3 PIK3C2A
39 stroke, ischemic 30.0 ACE CDKN2B-AS1 CRP F3 PLAT SELP
40 marantic endocarditis 29.9 F3 PLAT
41 peripheral artery disease 29.9 ACE CDKN2B-AS1 CRP SELP
42 intermediate coronary syndrome 29.8 ACE CRP F3 MB PIK3C2A PLAT
43 dilated cardiomyopathy 29.8 ACE ADRB1 CRP FABP3 MB MIR499A
44 subendocardial infarction acute myocardial infarction 12.4
45 strictly posterior acute myocardial infarction 12.3
46 coronary artery disease, autosomal dominant, 1 11.4
47 acute inferoposterior infarction 11.3
48 acute inferolateral myocardial infarction 11.3
49 coronary artery disease, autosomal dominant 2 11.3
50 hyperlipoproteinemia, type iii 11.3

Comorbidity relations with Acute Myocardial Infarction via Phenotypic Disease Network (PDN): (show all 22)


Active Peptic Ulcer Disease Acute Cystitis
Acute Kidney Failure Aortic Valve Disease 1
Cardiac Arrest Chronic Kidney Failure
Chronic Myocardial Ischemia Decubitus Ulcer
Deficiency Anemia Familial Atrial Fibrillation
Generalized Atherosclerosis Heart Disease
Hypertension, Essential Intermediate Coronary Syndrome
Ischemic Heart Disease Kidney Disease
Mitral Valve Disease Peripheral Vascular Disease
Protein-Energy Malnutrition Respiratory Failure
Schizophreniform Disorder Transient Cerebral Ischemia

Graphical network of the top 20 diseases related to Acute Myocardial Infarction:



Diseases related to Acute Myocardial Infarction

Symptoms & Phenotypes for Acute Myocardial Infarction

UMLS symptoms related to Acute Myocardial Infarction:


angina pectoris, chest pain

MGI Mouse Phenotypes related to Acute Myocardial Infarction:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.32 ACE ADRB1 CRP F3 FABP3 MB

Drugs & Therapeutics for Acute Myocardial Infarction

Drugs for Acute Myocardial Infarction (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 568)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved Phase 4,Phase 2,Phase 3,Not Applicable 51-61-6, 62-31-7 681
2
Metoclopramide Approved, Investigational Phase 4 364-62-5 4168
3
Morphine Approved, Investigational Phase 4,Phase 3,Not Applicable 57-27-2 5288826
4
Ticagrelor Approved Phase 4,Phase 2,Phase 3,Not Applicable 274693-27-5 9871419
5
Pravastatin Approved Phase 4 81093-37-0 54687
6
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 22916-47-8 4189
7
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53123-88-9 46835353 6436030 5284616
8
Abciximab Approved Phase 4,Phase 3,Phase 2,Not Applicable 143653-53-6
9
Everolimus Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 159351-69-6 6442177
10
Clopidogrel Approved Phase 4,Phase 3,Phase 2,Not Applicable 113665-84-2, 120202-66-6 60606
11
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 50-78-2 2244
12
Thrombin Approved, Investigational Phase 4,Phase 3
13
Tenecteplase Approved Phase 4,Phase 3,Phase 2 191588-94-0
14
Bivalirudin Approved, Investigational Phase 4,Phase 3,Not Applicable 128270-60-0 16129704
15
Enoxaparin Approved Phase 4,Phase 3,Phase 2,Not Applicable 9005-49-6 772
16
Tirofiban Approved Phase 4,Phase 3,Not Applicable 144494-65-5 60947
17
Colchicine Approved Phase 4,Phase 3,Phase 2 64-86-8 6167 2833
18
Ticlopidine Approved Phase 4,Phase 3,Not Applicable 55142-85-3 5472
19
Nicorandil Approved, Investigational Phase 4,Phase 3,Not Applicable 65141-46-0 47528
20
Heparin Approved, Investigational Phase 4,Phase 3,Not Applicable 9005-49-6 772 46507594
21
Isoflurane Approved, Vet_approved Phase 4 26675-46-7 3763
22
Propofol Approved, Investigational, Vet_approved Phase 4,Not Applicable 2078-54-8 4943
23
Desflurane Approved Phase 4 57041-67-5 42113
24
Metformin Approved Phase 4,Phase 2,Phase 3 657-24-9 14219 4091
25
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7440-66-6
26
Insulin Glargine Approved Phase 4,Phase 3,Not Applicable 160337-95-1
27
Paclitaxel Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 33069-62-4 36314
28
Pantoprazole Approved Phase 4 102625-70-7 4679
29
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
30
Glimepiride Approved Phase 4,Phase 3 93479-97-1 3476
31
Glyburide Approved Phase 4,Phase 3 10238-21-8 3488
32
Gliclazide Approved Phase 4,Phase 3 21187-98-4 3475
33
Pioglitazone Approved, Investigational Phase 4,Phase 3 111025-46-8 4829
34
Apixaban Approved Phase 4,Phase 3 503612-47-3 10182969
35
Rivaroxaban Approved Phase 4,Phase 3 366789-02-8
36
Angiotensin II Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 11128-99-7, 68521-88-0, 4474-91-3 172198 65143
37
Valsartan Approved, Investigational Phase 4,Phase 3 137862-53-4 60846
38
Dalteparin Approved Phase 4,Phase 3,Not Applicable 9005-49-6
39 Nutmeg Approved Phase 4,Phase 3
40
Chlorhexidine Approved, Vet_approved Phase 4,Not Applicable 55-56-1 2713 9552079
41
Metoprolol Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 37350-58-6, 51384-51-1 4171
42
Lenograstim Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 135968-09-1
43
Simvastatin Approved Phase 4,Phase 3,Phase 2 79902-63-9 54454
44
Adenosine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 58-61-7 60961
45
Chromium Approved Phase 4,Phase 3,Phase 2,Not Applicable 7440-47-3 27668
46
Furosemide Approved, Vet_approved Phase 4,Phase 3 54-31-9 3440
47
Amlodipine Approved Phase 4,Phase 3 88150-42-9 2162
48
Cobalt Approved, Experimental Phase 4,Phase 3,Phase 2,Not Applicable 7440-48-4 104729
49
Warfarin Approved Phase 4,Phase 3,Not Applicable 81-81-2 6691 54678486
50
Bezafibrate Approved, Investigational Phase 4 41859-67-0 39042

Interventional clinical trials:

(show top 50) (show all 1312)
# Name Status NCT ID Phase Drugs
1 Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial Infarction Unknown status NCT02627950 Phase 4 Morphinhydrochloricum;Metoclopramide;Ticagrelor;Isotonic sodium chloride
2 Efficacy of Thrombosuction in Primary Percutaneous Coronary Intervention of Acute Myocardial Infarction Unknown status NCT01156662 Phase 4
3 Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study Unknown status NCT00688922 Phase 4 Pravastatin
4 Sirolimus Eluting Stenting in Acute Myocardial Infarction Unknown status NCT00288210 Phase 4
5 Anti-Restenosis After AMI by Erythropoietin Unknown status NCT00423020 Phase 4 Erythropoietin
6 Sodium Tanshinone IIA Sulfonate in Left Ventricular Remodeling Secondary to Acute Myocardial Infarction Unknown status NCT02524964 Phase 4 sodium tanshinone IIA sulfonate
7 Microvascular Reperfusion Utilizing Sonothrombolysis in Acute Myocardial Infarction (MRUSMI TRIAL) Unknown status NCT02170103 Phase 4 Microbubbles
8 Comparison of Primary PCI vs. Post-thrombolysis PCI as Reperfusion Strategies in STEMI Unknown status NCT02268669 Phase 4
9 Treating Acute MI Patients With Aggrastat on Their Way to Hospital Unknown status NCT00300833 Phase 4 Tirofiban
10 N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure Unknown status NCT00692718 Phase 4 Epadel, Eicosapentaenoic acid
11 Post-MI PET Scan Imaging of Inflammation Unknown status NCT02281305 Phase 4 Colchicine
12 Colchicine in ST-elevation Myocardial Infarction Unknown status NCT01936285 Phase 4 Colchicine 2 mg loading dose; 0.5 mg bid for 5 days;Placebo
13 Dissecting the Role of Distal Embolization of Athero-thrombotic Material in Primary PCI: the ThrombOticBurden and mIcrovAscularobStruction (TOBIAS) Study. Unknown status NCT01914055 Phase 4
14 Evaluation of Neointimal Coverage of EES and BMS After Implantation in STEMI Patients by Optical Coherence Tomography Unknown status NCT01875835 Phase 4
15 Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI Unknown status NCT00229515 Phase 4
16 P3AMI Antiplatelet Trial Unknown status NCT02376283 Phase 4 Prasugrel;Clopidogrel;ticagrelor
17 Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome Unknown status NCT02037412 Phase 4 Ticagrelor;Clopidogrel
18 The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients Unknown status NCT02850627 Phase 4 Tongguan capsule;placebo capsule
19 Vitamin D and Inflammatory Cytokine Levels After Acute Myocardial Infraction (MI) Unknown status NCT01115842 Phase 4 Vitamin D
20 Treatment of Reperfusion Event by Vitamin C Infusion Unknown status NCT01090895 Phase 4 Vitamin C;Placebo
21 Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction Unknown status NCT02435797 Phase 4 Nicorandil;normal saline
22 Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome Unknown status NCT02446730 Phase 4 Prasugel;Clopidogrel
23 Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction Unknown status NCT00976092 Phase 4 Prasugrel;Bivalirudin;Clopidogrel;Heparin
24 Thrombus Aspiration for OcLuded Coronary Artery Enhanced With Distal Injection Of Abciximab Unknown status NCT01383785 Phase 4
25 Desflurane-induced Myocardial Protection Unknown status NCT02019797 Phase 4 Desflurane
26 Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI Unknown status NCT02233790 Phase 4 Ticagrelor;Clopidogrel
27 Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD) Unknown status NCT01035528 Phase 4 insulin glargine;metformin
28 Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI Unknown status NCT02792712 Phase 4 Ticagrelor;Clopidogrel
29 CT Coronary Angiogram Versus Traditional Care in Emergency Department Assessment of Potential ACS Unknown status NCT00933400 Phase 4
30 Multifactorial Intervention in Type 2 Diabetes - Italy Unknown status NCT01240070 Phase 4
31 Xience/Promus for Long Coronary Lesion Registry Unknown status NCT01147237 Phase 4
32 Treatment of Coronary In-Stent Restenosis Unknown status NCT01735825 Phase 4
33 Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN) Unknown status NCT01735227 Phase 4 omeprazole;Pantoprazole
34 Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial Unknown status NCT00700856 Phase 4 add-on pioglitazone;add-on sulphonylurea
35 Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation Unknown status NCT02666157 Phase 4 Dabigatran etexilate;Rivaroxaban;Apixaban
36 A Morbidity-Mortality and Remodeling Study With Valsartan Unknown status NCT00133328 Phase 4 valsartan
37 The Pacing vs No Pacing Study - PNP Study Unknown status NCT02498639 Phase 4
38 The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI Unknown status NCT02658838 Phase 4 Ticagrelor;full amount low molecular weight heparin;half amount low molecular weight heparin;No low molecular weight heparin
39 The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy) Unknown status NCT02767401 Phase 4 aspirin, clopidogrel, ticagrelor, atorvastatin, rosuvastatin, betaloc
40 Bezafibrate for Hyperfibrinogenemia in Acute Myocardial Infarction Completed NCT02291796 Phase 4 Bezafibrate
41 Effect of Complementary Intracoronary Streptokinase Administration Immediately After Primary Percutaneous Coronary Intervention on Microvascular Perfusion and Late Term Infarct Size in Patients With Acute Myocardial Infarction Completed NCT00302419 Phase 4 intracoronary infusion,
42 GPIIbIIIa Inhibitors in the RESCUe and RESURCOR Networks at the Acute Myocardial Infarction Completed NCT00538317 Phase 4 tirofiban;tirofiban
43 REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction Completed NCT01381185 Phase 4 Aspirin 200mg qd, Clopidogrel 2x75mg qd
44 Tight Glycemic Control Increases Cardiac Stem Cells During Acute Myocardial Infarction Completed NCT00863629 Phase 4 Insulin
45 The Effect of Erythropoietin at the Time of Reperfusion in Acute Myocardial Infarction Completed NCT00882466 Phase 4 human recombinant erythropoietin
46 BivaliRudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin :a Randomised Controlled Trial. Completed NCT01696110 Phase 4 Bivalirudin;heparin;heparin plus tirofiban
47 Southwest German Interventional Study in Acute Myocardial Infarction III Completed NCT01124890 Phase 4
48 Effects of Different Vasodilators on Coronary No-reflow During primAry percuTaneous Coronary intErvention in Patients With Acute Myocardial Infarction Completed NCT00712894 Phase 4 Diltiazem;Verapamil;Nitroglycerin
49 Safety and Efficacy of Three Different Loading Doses of Clopidogrel, in Patients With Acute Myocardial Infarction Completed NCT00882739 Phase 4 Clopidogrel 300 mg;Clopidogrel 600 mg;Clopidogrel 900 mg
50 Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction Completed NCT00627809 Phase 4 Streptokinase

Search NIH Clinical Center for Acute Myocardial Infarction

Genetic Tests for Acute Myocardial Infarction

Anatomical Context for Acute Myocardial Infarction

MalaCards organs/tissues related to Acute Myocardial Infarction:

41
Heart, Bone, Endothelial, Bone Marrow, Testes, Kidney, Brain

Publications for Acute Myocardial Infarction

Articles related to Acute Myocardial Infarction:

(show top 50) (show all 4323)
# Title Authors Year
1
Soluble regulators of Interleukin-1 signaling: Novel biomarkers for early acute myocardial infarction diagnosis and to predict ischemia/reperfusion injury? ( 30449335 )
2019
2
Copeptin as a prognostic biomarker in acute myocardial infarction. ( 30217427 )
2019
3
Associations of left atrial volumes and Doppler filling indices with left atrial function in acute myocardial infarction. ( 29961999 )
2019
4
Cyclin dependent kinase inhibitor 1 C is a female-specific marker of left ventricular function after acute myocardial infarction. ( 30077532 )
2019
5
MicroRNAs in pathophysiology of acute myocardial infarction and cardiogenic shock. ( 29947233 )
2018
6
rLj-RGD3, a novel recombinant toxin protein from Lampetra japonica, prevents coronary thrombosis-induced acute myocardial infarction by inhibiting platelet functions in rats. ( 29407168 )
2018
7
Circulating miR-379 as a potential novel biomarker for diagnosis of acute myocardial infarction. ( 29424915 )
2018
8
Meta-Analysis of Cell Therapy Studies in Heart Failure and Acute Myocardial Infarction. ( 29976694 )
2018
9
Toll-Like Receptors 2 and 4 Predict New-Onset Atrial Fibrillation in Acute Myocardial Infarction Patients. ( 29375116 )
2018
10
Acute Myocardial Infarction in a Patient with Isolated Dextrocardia. ( 29431312 )
2018
11
Acute myocardial infarction after blunt chest wall trauma with underlying coronary aneurysm: a case report. ( 29914384 )
2018
12
Chart validation of inpatient ICD-9-CM administrative diagnosis codes for acute myocardial infarction (AMI) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database. ( 29446185 )
2018
13
Impact of generalized anxiety disorder (GAD) on prehospital delay of acute myocardial infarction patients. Findings from the multicenter MEDEA study. ( 29383439 )
2018
14
Ac-SDKP decreases mortality and cardiac rupture after acute myocardial infarction. ( 29364896 )
2018
15
Atrioventricular block after acute myocardial infarction and its association with other clinical parameters in Pakistani patients: an institutional perspective. ( 29784020 )
2018
16
Effects of smoke-free air law on acute myocardial infarction hospitalization in Indianapolis and Marion County, Indiana. ( 29426315 )
2018
17
Hospital mortality and thirty day readmission among patients with non-acute myocardial infarction related cardiogenic shock. ( 29929933 )
2018
18
Revascularization strategies in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis. ( 29909948 )
2018
19
Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support. ( 29400656 )
2018
20
Functional genetic variants in the SIRT5 gene promoter in acute myocardial infarction. ( 29981421 )
2018
21
Cardiac rupture during acute myocardial infarction diagnosed clinically. ( 29394186 )
2018
22
Accelerated idioventricular rhythm degenerating into bidirectional ventricular tachycardia following acute myocardial infarction. ( 29429799 )
2018
23
Blood cardioplegia for cardiac surgery in acute myocardial infarction: rat experiments with two widely used solutions. ( 29452370 )
2018
24
Buckberg's blood cardioplegia for protection of adult and senile myocardium in a rat in vitro model of acute myocardial infarction. ( 29432894 )
2018
25
Cytomegalovirus infection in a patient with systemic lupus erythematosus and acute myocardial infarction - cause or causal relationship? ( 29915649 )
2018
26
Efficacy and Safety of Cyclosporine in Acute Myocardial Infarction: A Systematic Review and Meta-Analysis. ( 29970999 )
2018
27
Idiopathic Sudden Sensorineural Hearing Loss Is Not a Sentinel Event for Acute Myocardial Infarction. ( 29912831 )
2018
28
A foreign older diabetic woman with an acute myocardial infarction: when cognitive biases in clinical decision-making become especially important. ( 29437739 )
2018
29
Clinical characteristics and value in early reperfusion therapy for new onset right bundle branch block in patients with acute myocardial infarction. ( 29467855 )
2018
30
Clinical Significance of Newly Diagnosed Diabetes Mellitus in the Era of DES for Acute Myocardial Infarction. ( 29441749 )
2018
31
Effects of Short-term High Dose Atorvastatin on Left Ventricular Remodeling in Patients with First Time Attack of Anterior Acute Myocardial Infarction. ( 29976277 )
2018
32
Gambogic acid exerts cardioprotective effects in a rat model of acute myocardial infarction through inhibition of inflammation, iNOS and NF-I_B/p38 pathway. ( 29434760 )
2018
33
Acute stress disorder and C-reactive protein in patients with acute myocardial infarction. ( 29488809 )
2018
34
Prognostic value of new-onset right bundle-branch block in acute myocardial infarction patients: a systematic review and meta-analysis. ( 29576967 )
2018
35
Folic Acid-Derived Hydrogel Enhances the Survival and Promotes Therapeutic Efficacy of iPS Cells for Acute Myocardial Infarction. ( 29974744 )
2018
36
MicroRNAs in acute myocardial infarction: Evident value as novel biomarkers? ( 29424735 )
2018
37
2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: comments from the Dutch ACS working group. ( 29974355 )
2018
38
Rapid increases in nitrogen oxides are associated with acute myocardial infarction: A case-crossover study. ( 29446990 )
2018
39
Acute myocardial infarction in a 25-year-old woman with sitosterolemia. ( 29174072 )
2018
40
Persistent Inflammation, Stem Cell-Induced Systemic Anti-Inflammatory Effects, and Need for Repeated Stem Cell Injections: Critical Concepts Influencing Optimal Stem Cell Strategies for Treating Acute Myocardial Infarction and Heart Failure. ( 29440037 )
2018
41
Fried food intake and risk of nonfatal acute myocardial infarction in the Costa Rica Heart Study. ( 29447246 )
2018
42
Recurrent Acute Myocardial Infarction Caused by Intra-cardiac Metastatic Undifferentiated Pleomorphic Sarcoma during Cancer Treatment. ( 29629023 )
2018
43
Long-Term Prognostic Implications of Previous Silent Myocardial Infarction in Patients Presenting With Acute Myocardial Infarction. ( 29680352 )
2018
44
A Preliminary Study of microRNA-208b after Acute Myocardial Infarction: Impact on 6-Month Survival. ( 29977411 )
2018
45
Effects of low dose of aliskiren on isoproterenol-induced acute myocardial infarction in rats. ( 29975120 )
2018
46
Gene expression pattern of TCR repertoire and alteration expression of IL-17A gene of I^I' T cells in patients with acute myocardial infarction. ( 29976209 )
2018
47
Revision: prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock-a substudy of the IABP-SHOCK II-trial. ( 29423774 )
2018
48
Correction to: Air quality and acute myocardial infarction in adults during the 2016 Hangzhou G20 summit. ( 29450769 )
2018
49
Acute myocardial infarction in a patient with a recent diagnosis of Crohn's disease. ( 29954623 )
2018
50
Effect of a Quality Improvement Intervention on Clinical Outcomes in Patients in India With Acute Myocardial Infarction: The ACS QUIK Randomized Clinical Trial. ( 29450524 )
2018

Variations for Acute Myocardial Infarction

Copy number variations for Acute Myocardial Infarction from CNVD:

7
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 210497 6 30400000 36600000 Amplification C4B Acute myocardial infarction

Expression for Acute Myocardial Infarction

LifeMap Discovery
Genes differentially expressed in tissues of Acute Myocardial Infarction patients vs. healthy controls: 35
# Gene Description Tissue Up/Dn Fold Change (log2) P value
1 EGR3 early growth response 3 Blood + 5.52 0.000
2 LOC286058 uncharacterized LOC286058 Blood + 4.73 0.000
3 CXCL8 chemokine (C-X-C motif) ligand 8 Blood + 3.51 0.004
4 LEP leptin Heart + 3.45 0.011
5 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein Blood + 3.18 0.007
Search GEO for disease gene expression data for Acute Myocardial Infarction.

Pathways for Acute Myocardial Infarction

Pathways related to Acute Myocardial Infarction according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 9.98 ACE PLAT

GO Terms for Acute Myocardial Infarction

Cellular components related to Acute Myocardial Infarction according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.23 ACE CRP F3 FABP3 MIR29A NPPB

Biological processes related to Acute Myocardial Infarction according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of vascular endothelial cell proliferation GO:1905564 9.26 MIR29A MIR499A
2 heart contraction GO:0060047 9.16 ACE TNNI3
3 regulation of blood vessel diameter GO:0097746 8.96 ACE NPPB
4 transition between fast and slow fiber GO:0014883 8.62 MIR208B MIR499A

Sources for Acute Myocardial Infarction

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....